Tag Archives: Fluxion Biosciences

Fluxion Biosciences announced today a foundational patent has been issued for its ERASE-Seq technology, US patent 10,294,518, ‘Methods and Systems for Ultra-sensitive Detection of Genomic Alterations’. The ERASE-Seq technology and testing approach leverage inter-sample statistical analysis, rather than tracking of ...

The Spotlight 59™ panel and novel ERASE-Seq methodology are designed for ultra-sensitive variant detection from CTCs and cfDNA Fluxion Biosciences, Inc. announced the launch of the Spotlight 59 Oncology Panel. Designed for the detection of mutations from liquid biopsy samples, ...